Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients
- PMID: 15962361
- PMCID: PMC4315947
- DOI: 10.3748/wjg.v11.i23.3491
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients
Abstract
Aim: In the USA, Hawaii has the highest incidence of hepatocellular carcinoma (HCC) and a diverse population. It is an ideal place to characterize HCC in the context of ethnicity/risk factors.
Methods: A total of 262 cases of HCC (1992-2003) were retrospectively reviewed for demographics, ethnicity, birthplace, viral hepatitis, alcohol use, diabetes, smoking and risk factors for viral hepatitis such as intravenous drug abuse (IVDA), transfusions, tattoos and vertical transmission. Tumor stage, Child's class, Cancer of the Liver Italian Program (CLIP) score, alpha-fetoprotein level, treatment and survival were recorded.
Results: Gender, age, viral hepatitis, alcohol, IVDA, and diabetes differed significantly in Asians, non-Asians and Pacific Islanders. There were also specific differences within Asian subgroups. Alpha-fetoprotein, smoking, transfusions, stage and resectability did not differ between groups. Asians were more likely to have hepatitis B, while non-Asians were more likely to have hepatitis C. Factors that decreased survival included hepatitis B, alcohol, elevated alpha-fetoprotein, CLIP>2 and increased Child's class. When Asians were combined with Pacific Islanders, median survival (1.52 years vs 3.54 years), 1- and 3-year survival was significantly worse than those for non-Asians. After Cox regression analysis for hepatitis B and alcohol, there was no difference in survival by ethnicity.
Conclusion: Various ethnicities have different risk factors for HCC. Hepatitis B, alcohol, and alpha-fetoprotein are more important factors for survival than ethnicity.
Figures







Similar articles
-
Hepatocellular cancer: risk factors and survival in Pacific Islanders compared to Caucasians in Hawaii.Ethn Dis. 2010 Spring;20(2):169-73. Ethn Dis. 2010. PMID: 20503898
-
Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma.Liver Int. 2021 Aug;41(8):1922-1932. doi: 10.1111/liv.14877. Epub 2021 Apr 1. Liver Int. 2021. PMID: 33713386
-
Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.World J Gastroenterol. 2017 Jun 14;23(22):4054-4063. doi: 10.3748/wjg.v23.i22.4054. World J Gastroenterol. 2017. PMID: 28652658 Free PMC article.
-
[Current therapeutic strategies in hepatocellular carcinoma, Part 1].Leber Magen Darm. 1994 Jul;24(4):150, 153-4. Leber Magen Darm. 1994. PMID: 7934608 Review. German.
-
Alcohol and hepatocellular carcinoma: a review and a point of view.World J Gastroenterol. 2014 Nov 21;20(43):15943-54. doi: 10.3748/wjg.v20.i43.15943. World J Gastroenterol. 2014. PMID: 25473148 Free PMC article. Review.
Cited by
-
Smoking and hepatocellular carcinoma mortality.Exp Ther Med. 2012 Jan;3(1):124-128. doi: 10.3892/etm.2011.351. Epub 2011 Sep 19. Exp Ther Med. 2012. PMID: 22969856 Free PMC article.
-
Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii.Hepatol Int. 2008 Dec;2(4):478-85. doi: 10.1007/s12072-008-9103-0. Epub 2008 Oct 15. Hepatol Int. 2008. PMID: 19669323 Free PMC article.
-
Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation.BMC Cancer. 2009 Feb 4;9:46. doi: 10.1186/1471-2407-9-46. BMC Cancer. 2009. PMID: 19193234 Free PMC article.
-
Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.PLoS One. 2014 May 15;9(5):e95485. doi: 10.1371/journal.pone.0095485. eCollection 2014. PLoS One. 2014. PMID: 24830459 Free PMC article.
-
Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans.J Immigr Minor Health. 2011 Oct;13(5):842-8. doi: 10.1007/s10903-010-9395-8. J Immigr Minor Health. 2011. PMID: 20890660 Free PMC article.
References
-
- Simonetti RG, Cammà C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci. 1991;36:962–972. - PubMed
-
- El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35:S72–S78. - PubMed
-
- el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5:87–107, vi. - PubMed
-
- El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750. - PubMed
-
- Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31–48. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical